Andrew D. Zelenetz

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Roland Schmitz, George W. Wright, Da Wei Huang et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text

Medicine, Genetics, Oncology +12

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elı́as Campo, Elaine S. Jaffe, James R. Cook et al. · Blood · 2022 · 1.5K citations · Full text

Veterinary Medicine, Hematology, Oncology +17

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 953 citations

Medicine, Hematology, Oncology +14

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Kenneth R. Carson, Andrew M. Evens, Elizabeth Richey et al. · Blood · 2009 · 870 citations · Full text

Medicine, Immunology, Neurology +9